Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia
Transcranial magnetic stimulation (TMS) is a powerful tool to probe in vivo brain circuits, as it
allows to assess several cortical properties such as excitability, plasticity and connectivity in …
allows to assess several cortical properties such as excitability, plasticity and connectivity in …
The role of noradrenaline in cognition and cognitive disorders
Many aspects of cognition and behaviour are regulated by noradrenergic projections to the
forebrain originating from the locus coeruleus, acting through alpha and beta …
forebrain originating from the locus coeruleus, acting through alpha and beta …
α-Synucleinopathy phenotypes
H McCann, CH Stevens, H Cartwright… - Parkinsonism & related …, 2014 - Elsevier
Summary α-Synucleinopathies are neurodegenerative diseases characterised by the
abnormal accumulation of α-synuclein aggregates in neurons, nerve fibres or glial cells …
abnormal accumulation of α-synuclein aggregates in neurons, nerve fibres or glial cells …
Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the …
Purpose Patients suffering from cardiovascular autonomic failure often develop neurogenic
supine hypertension (nSH), ie, high blood pressure (BP) in the supine position, which falls in …
supine hypertension (nSH), ie, high blood pressure (BP) in the supine position, which falls in …
Neuropathology underlying clinical variability in patients with synucleinopathies
Abnormal aggregates of the synaptic protein, α-synuclein, are the dominant pathology in
syndromes known as the synucleinopathies. The cellular aggregation of the protein occurs …
syndromes known as the synucleinopathies. The cellular aggregation of the protein occurs …
Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study
Y Miki, SC Foti, YT Asi, E Tsushima, N Quinn, H Ling… - Brain, 2019 - academic.oup.com
Clinical diagnosis of multiple system atrophy is challenging and many patients with Lewy
body disease (ie Parkinson's disease or dementia with Lewy bodies) or progressive …
body disease (ie Parkinson's disease or dementia with Lewy bodies) or progressive …
Multiple system atrophy: an oligodendroglioneural synucleinopathy
KA Jellinger - Journal of Alzheimer's Disease, 2018 - content.iospress.com
Multiple system atrophy (MSA) is an orphan, fatal, adult-onset neurodegenerative disorder of
uncertain etiology that is clinically characterized by various combinations of parkinsonism …
uncertain etiology that is clinically characterized by various combinations of parkinsonism …
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
Background In preclinical studies, davunetide promoted microtubule stability and reduced
tau phosphorylation. Because progressive supranuclear palsy (PSP) is linked to tau …
tau phosphorylation. Because progressive supranuclear palsy (PSP) is linked to tau …
Diagnosis of multiple system atrophy
Multiple system atrophy (MSA) may be difficult to distinguish clinically from other disorders,
particularly in the early stages of the disease. An autonomic-only presentation can be …
particularly in the early stages of the disease. An autonomic-only presentation can be …
The neuropathology, pathophysiology and genetics of multiple system atrophy
Z Ahmed, YT Asi, A Sailer, AJ Lees… - Neuropathology and …, 2012 - Wiley Online Library
Z. Ahmed, YT Asi, A. Sailer, AJ Lees, H. Houlden, T. Revesz and JL Holton (2012)
Neuropathology and Applied Neurobiology38, 4–24 The neuropathology, pathophysiology …
Neuropathology and Applied Neurobiology38, 4–24 The neuropathology, pathophysiology …